» Articles » PMID: 29507498

Knowledge of HPV/cervical Cancer and Acceptability of HPV Self-sampling Among Women Living with HIV: A Scoping Review

Overview
Journal Curr Oncol
Publisher MDPI
Specialty Oncology
Date 2018 Mar 7
PMID 29507498
Citations 16
Authors
Affiliations
Soon will be listed here.
Abstract

Cervical cancer rates are disproportionately high among women living with the human immunodeficiency virus (wlhiv). Cervical cancer is preventable through hpv screening, regular Pap tests, and early cancer detection. Evidence indicates that hpv and cervical cancer screening are suboptimal among wlhiv, who face a myriad of access barriers. Considering that screening is an effective first-line defense to cervical cancer, we conducted a scoping review with the aim of gaining a better understanding about: (1) the knowledge and perceptions of hpv and cervical cancer screening among wlhiv; and (2) the acceptability of self-sampling for hpv among wlhiv. We searched five electronic databases for peer-reviewed articles that were published in English within the last ten years, reported on studies with hiv-positive women who were aged 16 or older, and satisfied the topics of the review. A total of 621 articles were found. After accounting for duplicates and unmet criteria, 17 articles and 1 abstract, reporting on studies in the United States and Africa, were included in this review. The review highlighted that most wlhiv had inadequate knowledge of hpv transmission and cervical cancer prevention, which influenced their perceptions of risk and susceptibility. Screening barriers included misconceptions about Pap tests, fear of diagnosis of serious illness, perceived pain, embarrassment, bodily modesty, and limited access to female health care providers. This review also affirms that self-sampling is an acceptable and promising screening option for wlhiv. Implications for policy, research, and practice are discussed.

Citing Articles

Acceptability of self-sampling and self-testing for infections: a rapid systematic review on public users' views.

Borek A, Roleston C, Lazzarino R, Cooray M, Hayward G, Roberts N BMC Public Health. 2025; 25(1):695.

PMID: 39972444 PMC: 11841015. DOI: 10.1186/s12889-025-21773-w.


Breaking Barriers: Empowering Cervical Cancer Screening with HPV Self-Sampling for Sex Workers and Formerly Incarcerated Women in Toronto.

Vahabi M, Hynes J, Wong J, Kithulegoda N, Moosapoor M, Akbarian A Curr Oncol. 2024; 31(12):7994-8009.

PMID: 39727713 PMC: 11674614. DOI: 10.3390/curroncol31120590.


A correlation study between cervical cancer and sex hormones.

Wu X, You Y, Guan Z, Ban Y, Wang Y, Du D Front Oncol. 2024; 14:1475052.

PMID: 39678493 PMC: 11638056. DOI: 10.3389/fonc.2024.1475052.


Human papillomavirus self-sampling versus provider-sampling in low- and middle-income countries: a scoping review of accuracy, acceptability, cost, uptake, and equity.

Otieno J, Were L, Nyanchoka M, Olwanda E, Mulaku M, Sem X Front Public Health. 2024; 12:1439164.

PMID: 39678248 PMC: 11638174. DOI: 10.3389/fpubh.2024.1439164.


Opportunities for cancer prevention at syringe services programs: acceptability of HPV self-sampling and vaccination among people who inject drugs.

Hinkes S, Ciraldo K, Kobetz E, Bartholomew T, Rinehart S, Siringo N Harm Reduct J. 2024; 21(1):70.

PMID: 38539215 PMC: 10967053. DOI: 10.1186/s12954-024-00982-3.


References
1.
Bukirwa A, Mutyoba J, Mukasa B, Karamagi Y, Odiit M, Kawuma E . Motivations and barriers to cervical cancer screening among HIV infected women in HIV care: a qualitative study. BMC Womens Health. 2015; 15:82. PMC: 4603977. DOI: 10.1186/s12905-015-0243-9. View

2.
Cobucci R, Henrique Lima P, de Souza P, Costa V, Cornetta M, Fernandes J . Assessing the impact of HAART on the incidence of defining and non-defining AIDS cancers among patients with HIV/AIDS: a systematic review. J Infect Public Health. 2014; 8(1):1-10. DOI: 10.1016/j.jiph.2014.08.003. View

3.
Koneru A, Jolly P, Blakemore S, McCree R, Lisovicz N, Aris E . Acceptance of peer navigators to reduce barriers to cervical cancer screening and treatment among women with HIV infection in Tanzania. Int J Gynaecol Obstet. 2017; 138(1):53-61. PMC: 5482416. DOI: 10.1002/ijgo.12174. View

4.
Levac D, Colquhoun H, OBrien K . Scoping studies: advancing the methodology. Implement Sci. 2010; 5:69. PMC: 2954944. DOI: 10.1186/1748-5908-5-69. View

5.
Wigfall L, Bynum S, Brandt H, Friedman D, Bond S, Lazenby G . Cervical Cancer Prevention Knowledge and Abnormal Pap Test Experiences Among Women Living with HIV/AIDS. J Cancer Educ. 2014; 30(2):213-9. PMC: 4266621. DOI: 10.1007/s13187-014-0688-9. View